Brief: Suven Life Sciences Says U.S. FDA Issued EIR For Co's Facility At Pashamylaram

Suven Life Sciences

07/05/2018 09:19

May 7 (Reuters) - Suven Life Sciences Ltd  SUVP.NS :
    * SAYS SUVEN'S PASHAMYLARAM'S UNIT SUCCESSFULLY COMPLETES US
FDA
INSPECTION
    * FDA DETERMINED THAT THE INSPECTION CLASSIFICATION OF THIS
FACILITY IS “NO ACTION INDICATED
    * BASED ON INSPECTION, FACILITY CONSIDERED TO BE IN
ACCEPTABLE
STATE OF COMPLIANCE W.R.T. CURRENT GOOD MANUFACTURING PROCESSES 
    * FDA ISSUED ESTABLISHMENT INSPECTION REPORT FOR SUVEN
FACILITY AT
PASHAMYLARAM

Source text - http://bit.ly/2KFOLJP
Further company coverage:  SUVP.NS 

 ((Reuters.Briefs@thomsonreuters.com;))